Bacterial superantigens are extremely potent activators of the immune
system. Their ability to efficiently cross-link molecules of the major
histocompatibility complex class II and T-cell receptors causes the n
ormal antigen specificity of each receptor to be bypassed. Two well ch
aracterized superantigens are the staphylococcal enterotoxins A and B.
Data from mutagenesis studies in combination with recent structural i
nformation allow the definition of the surfaces on these superantigens
involved in the binding of either type of receptor. Wild-type and eng
ineered mutants of these superantigens have been used to modulate the
activity of cells in the immune system, in an attempt to develop thera
peutics applications.